Competence and competition: the challenge of becoming a long-lived plasma cell, Nat Rev Immunol, vol.6, issue.10, pp.741-50, 2006. ,
The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Classification WHO 2016 des tumeurs des tissus hématopoïétiques et lymphoïdes Swerdlow SH, vol.127, pp.2375-90, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01800015
The biology and treatment of plasmablastic lymphoma, Blood, vol.125, issue.15, pp.2323-2353, 2015. ,
Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation, Diagnostics différentiels des infiltrats plasmocytaires, vol.74, pp.878-84, 2016. ,
Hématopoïèse normale et sa régulation, EMC Hématologie, vol.11, issue.1, pp.1-16, 2016. ,
Plasma cell development: from B-cell subsets to longterm survival niches, Semin Immunol, vol.20, issue.1, pp.49-58, 2008. ,
Plasma cell development and survival, Immunol Rev, vol.237, issue.1, pp.140-59, 2010. ,
Regulation of plasma-cell development, Nat Rev Immunol, vol.5, issue.3, pp.230-272, 2005. ,
Classification histopathologique, immunologique, cytogénétique et moléculaire des lymphomes non hodgkiniens, EMCHématologie, pp.1-23, 2009. ,
Competence and competition: the challenge of becoming a long-lived plasma cell, Nat Rev Immunol, vol.6, issue.10, pp.741-50, 2006. ,
Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation, J Exp Med, vol.203, issue.4, pp.1081-91, 2006. ,
Plasma-cell homing, Nat Rev Immunol, vol.3, issue.10, pp.822-831, 2003. ,
Plasma cell and memory B cell differentiation from the germinal center, Curr Opin Immunol, vol.45, pp.97-102, 2017. ,
Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation, J Biochem, vol.141, issue.6, pp.783-792, 2007. ,
Regulatory mechanisms that determine the development and function of plasma cells, Annu Rev Immunol, vol.21, pp.205-235, 2003. ,
Primary cutaneous marginal zone lymphoma, Crit Rev Oncol Hematol, vol.74, issue.3, pp.156-62, 2010. ,
Gene interaction network regulates plasma cell differentiation, Scand J Immunol, vol.73, issue.6, pp.512-521, 2011. ,
Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population, J Exp Med, vol.195, issue.6, pp.737-782, 2002. ,
Plasma cell differentiation and survival, Curr Opin Immunol, vol.20, issue.2, pp.162-171, 2008. ,
Long-lived plasma cells in immunity and immunopathology, Immunol Lett, vol.103, issue.2, pp.83-88, 2006. ,
Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals, J Immunol, vol.171, issue.4, pp.1684-90, 2003. ,
Les marqueurs membranaires de surface (clusters de différenciation) utilisés en dermatopathologie (1) : les marqueurs lymphocytaires, Annales de Dermatologie et de Vénéréologie, vol.142, issue.10, pp.598-606, 2015. ,
Immunophénotypage lymphocytaire dans les syndromes lymphoprolifératifs chroniques, EMC -Biologie médicale, vol.8, issue.4, pp.1-13, 2013. ,
Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders, Cytometry B Clin Cytom, vol.78, issue.4, pp.239-52, 2010. ,
Immunophenotyping in multiple myeloma and related plasma cell disorders, Best Pract Res Clin Haematol, vol.23, issue.3, pp.433-51, 2010. ,
The discovery of plasma cells: An historical note, Immunol Lett, vol.188, pp.64-71, 2017. ,
Phenotypic difference of normal plasma cells from mature myeloma cells, Blood, vol.81, issue.10, pp.2658-63, 1993. ,
, , vol.12, pp.1-12, 2017.
, Lymphomes B cutanés. EMC -Hématologie, vol.11, issue.4, pp.1-9, 2016.
Prise en charge des lymphomes B cutanés: recommandations du Groupe français d'étude des lymphomes cutanés, Annales de dermatologie et de vénéréologie, pp.523-531, 2010. ,
TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC), Blood, vol.110, issue.2, pp.479-84, 2007. ,
The 2016 revision of the World Health Organization classification of lymphoid neoplasms, Blood, vol.127, issue.20, pp.2375-90, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01800015
Primary plasmacytoma of the skin, J Am Acad Dermatol, vol.34, issue.2, pp.386-90, 1996. ,
Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea, J Am Acad Dermatol, vol.78, issue.3, pp.471-479, 2018. ,
Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature, J Cutan Pathol, vol.29, issue.4, pp.244-252, 2002. ,
Plasmocytomes cutanés primitifs, Bagot M, éditeur. Les lymphomes cutanés: Sous l'égide du Groupe français d'étude des lymphomes cutanés, pp.199-202, 2013. ,
The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies, J Cutan Pathol, vol.35, issue.8, pp.705-726, 2008. ,
Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis, J Pathol, vol.205, issue.1, pp.92-101, 2005. ,
Manifestations dermatologiques des gammapathies monoclonales : apport de l'histopathologie cutanée, Annales de Pathologie, vol.35, issue.4, pp.281-93, 2015. ,
Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases, Arch Dermatol, vol.139, issue.4, pp.475-86, 2003. ,
Plasmocytome cutané primitif, Annales de Pathologie, vol.27, issue.2, pp.130-132, 2008. ,
Plasmocytomes cutanés primitifs multiples. Annales de Dermatologie et de Vénéréologie, vol.141, pp.364-372, 2014. ,
Skin Lymphoma: The Illustrated Guide, vol.440, 2014. ,
Cutaneous nodules as a diagnostic clue in multiple myeloma, Am J Dermatopathol, vol.35, issue.3, pp.377-80, 2013. ,
, AFIP Atlas of Tumor Pathology Series 4 | Lymph Node & Spleen, vol.25, 2017.
Multiple bulky cutaneous plasmacytomas with CNS relapse without bone marrow involvement during the course of a lambda light chain myeloma, Onkologie, vol.32, issue.11, pp.662-666, 2009. ,
Kappa light chain myeloma with initial cutaneous involvement, Ann Hematol, vol.85, issue.4, pp.272-276, 2006. ,
Monoclonal gammopathies and associated skin disorders, J Am Acad Dermatol, vol.40, issue.4, pp.536-544, 1999. ,
Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas, Arch Pathol Lab Med, vol.128, issue.6, pp.645-653, 2004. ,
Metastatic cutaneous plasmacytoma: a case report associated with IgA lambda multiple myeloma and a review of the literature of metastatic cutaneous plasmacytomas associated with multiple myeloma and primary cutaneous plasmacytomas, J Dermatol, vol.26, issue.9, pp.587-94, 1999. ,
, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4 e éd, vol.2, 2017.
Cutaneous extramedullary plasmacytoma: clinical, prognostic, and interphase cytogenetic analysis, Am J Dermatopathol, vol.35, issue.3, pp.357-63, 2013. ,
Multiple primary cutaneous plasmacytomas, Arch Dermatol, vol.128, issue.7, pp.962-967, 1992. ,
The spectrum of cutaneous disease in multiple myeloma, J Am Acad Dermatol, vol.48, issue.4, pp.497-507, 2003. ,
Case for diagnosis. Cutaneous involvement associated to multiple myeloma, An Bras Dermatol, vol.89, issue.1, pp.173-177, 2014. ,
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients, Leuk Lymphoma, vol.57, issue.9, pp.2071-2077, 2016. ,
Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach, J Clin Oncol, vol.29, issue.28, pp.3805-3817, 2011. ,
Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series, Curr Oncol, vol.23, issue.6, pp.630-676, 2016. ,
Primary cutaneous plasmacytoma in an HIV-positive patient, Int J Dermatol, vol.55, issue.4, pp.464-471, 2016. ,
A case of a primary cutaneous plasmacytoma presenting in adolescence, Am J Dermatopathol, vol.34, issue.5, pp.537-577, 2012. ,
Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression, J Am Acad Dermatol, vol.39, issue.3, pp.506-514, 1998. ,
Multiple myeloma with skin involvement, J Eur Acad Dermatol Venereol, vol.15, issue.4, pp.328-337, 2001. ,
Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder, Am J Dermatopathol, vol.32, issue.5, pp.479-85, 2010. ,
,
, Ann Dermatol Venereol, vol.131, issue.12, pp.1085-91, 2004.
Epstein-Barr virus-associated high-grade anaplastic plasmacytoma in a renal transplant patient, Leuk Lymphoma, vol.36, issue.3-4, pp.411-416, 2000. ,
Primary cutaneous plasmacytoma (posttransplant lymphoproliferative disorder, plasmacytoma-like) in a heart transplant patient, Am J Dermatopathol, vol.28, issue.5, pp.442-447, 2006. ,
Plasmocytome cutané EBV+ isolé chez une malade transplantée rénale : efficacité d'un traitement par rituximab, Annales de Dermatologie et de Vénéréologie, vol.131, issue.12, pp.1081-1085, 2004. ,
Cutaneous involvement in multiple myeloma mimicking acral-lentiginous melanoma, J Am Acad Dermatol, vol.62, issue.6, pp.1076-1084, 2010. ,
Multiple cutaneous plasmacytomas following an autologous peripheral stem cell transplant, Clin Exp Dermatol, vol.27, issue.4, pp.293-298, 2002. ,
Cutaneous Plasmacytoma: A Rare Complication of Multiple Myeloma and Permanent Pacemaker Insertion. Heart, Lung and Circulation, vol.27, p.159, 2018. ,
Metastasis of Multiple Myeloma at the Fracture Site, Ann Dermatol, vol.29, issue.4, pp.483-489, 2017. ,
Metastatic skin lesions of multiple myeloma presenting as two extraordinarily large subcutaneous tumors, Int J Dermatol, vol.52, issue.12, pp.1568-70, 2013. ,
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma, Br J Haematol, vol.124, issue.6, pp.717-743, 2004. ,
Skin involvement in immunoglobulin E multiple myeloma, J Clin Oncol, vol.27, issue.4, pp.637-645, 2009. ,
Plasmocytomes cutanés multiples traités par applications locales de miltéfosine, Annales de Dermatologie et de Vénéréologie, vol.131, issue.2, p.204, 2004. ,
Cutaneous involvement in multiple myeloma and bortezomib, Ann Hematol, vol.88, issue.11, pp.1137-1146, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00535041
Cutaneous myeloma and bortezomib, Ann Hematol, vol.88, issue.10, p.1045, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00535075
Radiotherapy for multiple myeloma with skin involvement, Curr Oncol, vol.17, issue.5, pp.74-81, 2010. ,
Radiation therapy for secondary cutaneous plasmacytomas, Case Rep Hematol, pp.1-5, 2013. ,
Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy, J Clin Oncol, vol.23, issue.13, pp.3138-3178, 2005. ,
Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation, J Am Acad Dermatol, vol.74, issue.5, pp.878-84, 2016. ,
Primary cutaneous plasmacytoma: report of a case with review of the literature, J Am Acad Dermatol, vol.43, issue.5, pp.962-967, 2000. ,
Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients, Int J Radiat Oncol Biol Phys, vol.64, issue.1, pp.210-217, 2006. ,
Extensive extramedullary disease in myeloma. An uncommon variant with features of poor prognosis and dedifferentiation, Cancer, vol.77, issue.7, pp.1298-302, 1996. ,
Cutaneous plasmacytomas secondary to nonsecretory multiple myeloma, J Dermatolog Clin Res, vol.2, issue.3, p.1022, 2014. ,
Cutaneous Waldenstrom's macroglobulinemia with « deck-chair » sign treated with cyclophosphamide, J Am Acad Dermatol, vol.52, issue.2, pp.45-52, 2005. ,
Cutaneous Infiltration due to Waldenström Macroglobulinemia, Actas Dermosifiliogr, vol.109, issue.1, pp.75-83, 2018. ,
Cutaneous macroglobulinosis: a report of 2 cases, Arch Dermatol, vol.146, issue.2, pp.165-174, 2010. ,
Cutaneous infiltration with Waldenström macroglobulinemia, Leuk Res, vol.30, issue.9, pp.1207-1217, 2006. ,
MYD88 L265P mutation in cutaneous involvement by Waldenström macroglobulinemia, J Cutan Pathol, 2017. ,
Cutaneous Waldenström's macroglobulinaemia, Clin Exp Dermatol, vol.28, issue.5, pp.491-493, 2003. ,
Cutaneous macroglobulinosis: a case series, J Cutan Pathol, vol.39, issue.10, pp.962-70, 2012. ,
Macroglobulinemia cutis, Arch Dermatol, vol.114, issue.2, pp.280-281, 1978. ,
Manifestations cutanées associées aux paraprotéines : mécanismes des atteintes cutanées, La Presse Médicale, vol.36, issue.7-8, pp.1135-1175, 2008. ,
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO), Br J Haematol, vol.179, issue.3, pp.439-487, 2017. ,
Cutaneous marginal zone lymphoma (cutaneous MALT lymphoma) and variants, Skin lymphoma, pp.201-220, 2014. ,
, WHO Classification of Skin Tumours. 4 e éd, vol.11, 2018.
Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States, Mod Pathol, vol.21, issue.12, pp.1517-1543, 2008. ,
Primary Cutaneous B-cell Lymphomas, Clin Lab Med, vol.37, issue.3, pp.547-74, 2017. ,
Primary Cutaneous B-Cell Lymphomas, Surg Pathol Clin, vol.7, issue.2, pp.253-83, 2014. ,
Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression, Mod Pathol, vol.26, issue.12, pp.1568-76, 2013. ,
Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets, Am J Surg Pathol, vol.34, issue.12, pp.1830-1871, 2010. ,
Cutaneous marginal zone lymphomas, Semin Diagn Pathol, vol.34, issue.1, pp.76-84, 2017. ,
Paraproteinaemia in Primary Cutaneous Marginal Zone Lymphoma, Acta Derm Venereol, vol.98, issue.10, pp.956-62, 2018. ,
Extranodal lymphomas of the head and neck, Ann Diagn Pathol, vol.9, issue.6, pp.340-50, 2005. ,
Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?, Am J Dermatopathol, vol.29, issue.3, pp.231-237, 2007. ,
Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype, Br J Dermatol, vol.177, issue.2, pp.564-570, 2017. ,
Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification, J Am Acad Dermatol, vol.69, issue.3, pp.341-343, 2013. ,
Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from its adult counterpart?, Br J Dermatol, vol.176, issue.4, pp.1010-1030, 2017. ,
Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature, Am J Dermatopathol, vol.35, issue.3, pp.319-345, 2013. ,
Classification of cutaneous lymphomas -an update, Histopathology, vol.56, issue.1, pp.57-70, 2010. ,
High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas, JAMA Dermatol, vol.150, issue.4, pp.412-420, 2014. ,
Primary cutaneous B-cell lymphomas: part II. Therapy and future directions, J Am Acad Dermatol, vol.69, issue.3, pp.343-344, 2013. ,
Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab, Eur J Dermatol, vol.20, issue.4, pp.533-537, 2010. ,
Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.24, issue.6, pp.149-54, 2013. ,
Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients, Journal of the American Academy of Dermatology, vol.69, issue.3, pp.357-65, 2013. ,
Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases, Br J Dermatol, vol.147, issue.6, pp.1147-58, 2002. ,
Cutaneous B-cell lymphomas: 2016 update on diagnosis, risk-stratification, and management, Am J Hematol, vol.91, issue.10, pp.1052-1057, 2016. ,
Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient, J Am Acad Dermatol, vol.67, issue.5, pp.202-207, 2012. ,
Plasmablastic lymphoma arising at a cutaneous site, Histopathology, vol.46, issue.1, pp.113-118, 2005. ,
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features, Mod Pathol, vol.23, issue.7, pp.991-1000, 2010. ,
Epstein-Barr virus-and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation, J Cutan Pathol, vol.32, issue.1, pp.35-44, 2005. ,
Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma, Br J Dermatol, vol.153, issue.4, pp.828-860, 2005. ,
HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases, Am J Hematol, vol.83, issue.10, pp.804-813, 2008. ,
Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles, Mod Pathol, vol.18, issue.6, pp.806-821, 2005. ,
Diffuse large Bcell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities, Am J Surg Pathol, vol.28, issue.6, pp.736-783, 2004. ,
,
, Ann Pathol, vol.25, issue.1, pp.45-54, 2005.
Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm, Am J Surg Pathol, vol.29, issue.12, pp.1633-1674, 2005. ,
Primary cutaneous plasmablastic lymphoma in an immunocompetent patient, J Am Acad Dermatol, vol.69, issue.5, pp.274-280, 2013. ,
KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma, J Cutan Pathol, vol.33, issue.2, pp.46-51, 2006. ,
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma, Blood, vol.95, issue.4, pp.1406-1418, 2000. ,
High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma, Leukemia, vol.19, issue.5, pp.851-856, 2005. ,
Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature, Am J Clin Pathol, vol.132, issue.4, pp.597-605, 2009. ,
Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis, Arch Pathol Lab Med, vol.140, issue.10, pp.1074-1082, 2016. ,
Diffuse large Bcell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome, Leukemia, vol.18, issue.1, pp.146-55, 2004. ,
The biology and treatment of plasmablastic lymphoma, Blood, vol.125, issue.15, pp.2323-2353, 2015. ,
IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas, Am J Surg Pathol, vol.34, issue.11, pp.1686-94, 2010. ,
Plasmablastic lymphoma: a review, Oral Dis, vol.15, issue.1, pp.38-45, 2009. ,
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection, Blood, vol.89, issue.4, pp.1413-1433, 1997. ,
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma, Oncologist, vol.15, issue.3, pp.293-302, 2010. ,
Post-transplant plasmablastic lymphoma of the skin, Australas J Dermatol, vol.54, issue.4, pp.277-82, 2013. ,
Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients, J Hematol Oncol, vol.8, p.65, 2015. ,
Human immunodeficiency virus-negative plasmablastic lymphoma: A case report and literature review, Medicine, vol.96, issue.7, p.6171, 2017. ,
Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation, Dermatology (Basel), vol.208, issue.3, pp.287-90, 2004. ,
Lymphome B cutané plasmablastique post-transplantation à type d'ulcère de jambe : premiere observation, Rev Méd Interne, vol.23, p.119, 2002. ,
Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review, Case Rep Hematol, pp.1-6, 2013. ,
Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy, J Clin Pathol, vol.60, issue.1, pp.80-81, 2007. ,
Cutaneous plasmablastic lymphoma in a nonimmunocompromised patient, J Am Acad Dermatol, vol.69, issue.6, pp.315-322, 2013. ,
Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?, Leuk Lymphoma, vol.59, issue.7, pp.1753-1758, 2018. ,
Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant, Pediatr Transplant, vol.13, issue.5, pp.628-659, 2009. ,
Vulvar plasmablastic lymphoma in a HIV-positive child: a novel extraoral localisation, J Clin Pathol, vol.62, issue.7, pp.644-650, 2009. ,
Cutaneous plasmablastic lymphoma, J Am Acad Dermatol, vol.58, issue.4, pp.676-684, 2008. ,
Post-transplant plasmablastic lymphoma of the skin, Br J Dermatol, vol.149, issue.4, pp.889-91, 2003. ,
Plasmablastic lymphoma presenting as exophytic skin lesions, Hematol Oncol Stem Cell Ther, vol.10, issue.3, pp.164-169, 2017. ,
A rare presentation of plasmablastic lymphoma as cutaneous nodules in an immunocompromised patient, Int J STD AIDS, vol.28, issue.6, pp.623-628, 2017. ,
Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone, J Clin Oncol, vol.28, issue.34, pp.704-712, 2010. ,
Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases, Am J Surg Pathol, vol.38, issue.7, pp.875-86, 2014. ,
HIV-negative plasmablastic lymphoma: not in the mouth, Clin Lymphoma Myeloma Leuk, vol.11, issue.2, pp.185-194, 2011. ,
Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background, Am J Clin Pathol, vol.133, issue.1, pp.59-69, 2010. ,
Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma, J Am Acad Dermatol, vol.19, issue.5, pp.879-90, 1988. ,
Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma, Ann Hematol, vol.94, issue.4, pp.691-693, 2015. ,
Plasmablastic lymphoma and related disorders, Am J Clin Pathol, vol.136, issue.2, pp.183-94, 2011. ,
, Actas Dermosifiliogr, vol.107, issue.8, pp.640-51, 2016.
, Surg Pathol Clin, vol.10, issue.2, pp.455-76, 2017.
IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma, Am J Surg Pathol, vol.33, issue.11, pp.1713-1722, 2009. ,
PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia, J Cutan Pathol, vol.42, issue.1, pp.6-15, 2015. ,
Clinicopathologic analysis of IgG4-related skin disease, Mod Pathol, vol.26, issue.4, pp.523-555, 2013. ,
Cutaneous immunoglobulin G4-related systemic disease, Am J Med, vol.124, issue.10, pp.7-8, 2011. ,
Immunoglobulin G4-related disease and its skin manifestations, J Dermatol, vol.44, issue.3, pp.288-96, 2017. ,
IgG4-related skin disease, Br J Dermatol, vol.171, issue.5, pp.959-67, 2014. ,
IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects, JAMA Dermatol, vol.149, issue.6, pp.742-749, 2013. ,
IgG4-related skin disease may have distinct systemic manifestations: a systematic review, Int J Dermatol, vol.55, issue.11, pp.1184-95, 2016. ,
IgG4-related skin manifestations in patients with IgG4-related disease, Eur J Dermatol, vol.23, issue.2, pp.241-246, 2013. ,
Isolated cutaneous manifestation of IgG4-related disease, J Clin Pathol, vol.65, issue.9, pp.815-823, 2012. ,
Cutaneous plasmacytosis: A rare entity with unique presentation, Indian J Dermatol Venereol Leprol, vol.83, issue.6, pp.673-679, 2017. ,
Cutaneous plasmacytosis: a clinicopathologic study of 12 cases in Taiwan revealing heterogeneous underlying causes, Int J Dermatol, vol.54, issue.10, pp.1132-1139, 2015. ,
Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement, J Am Acad Dermatol, vol.68, issue.6, pp.978-85, 2013. ,
Cutaneous Plasmacytosis: A Clinicopathologic Study of a Series of Cases and Their Treatment Outcomes, Am J Dermatopathol, vol.40, issue.1, pp.36-42, 2018. ,
Case of isolated benign primary cutaneous plasmacytosis in a child, J Dermatol, vol.38, issue.4, pp.364-371, 2011. ,
Lymphoplasmacytic plaque in children: a report of two new cases with review of the literature, Journal of cutaneous pathology, vol.40, issue.1, pp.50-55, 2013. ,
Tibial lymphoplasmacytic plaque: a new, illustrative case of a recently and poorly recognized benign lesion in children, Dermatology (Basel), vol.225, issue.1, pp.27-30, 2012. ,
Pretibial lymphoplasmacytic plaque in children, Arch Dermatol, vol.146, issue.1, pp.95-101, 2010. ,
Atypical presentations of cutaneous leishmaniasis: A systematic review, Acta Trop. août, vol.172, pp.240-54, 2017. ,
,
, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies
, Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité
, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences
, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses
, que je sois déshonoré(e) et méprisé(e) si j'y manque